Page last updated: 2024-08-21

isoxazoles and Synovitis

isoxazoles has been researched along with Synovitis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conde, C; García, S; Gómez-Reino, JJ; González, A; Martínez, P; Orosa, B1
Harman, H; Harman, S; Kaban, N; Tekeoğlu, I1
Davis, JM; Matteson, EL1
Nakayamada, S; Ra, C; Saito, K; Sawamukai, N; Tanaka, Y; Yamaoka, K1
Barg, EC; Breedveld, FC; Emery, P; Farnell, J; Kraan, MC; Reece, RJ; Rosenburg, R; Smeets, TJ; Tak, PP; Veale, DJ1
Breedveld, FC; Emery, P; Gibbon, WW; Kraan, MC; O'Connor, PJ; Radjenovic, A; Reece, RJ; Ridgway, JP; Tak, PP; Veale, DJ1

Reviews

1 review(s) available for isoxazoles and Synovitis

ArticleYear
My treatment approach to rheumatoid arthritis.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:7

    Topics: Abatacept; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Comorbidity; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunoconjugates; Isoxazoles; Joints; Leflunomide; Methotrexate; Prednisone; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Referral and Consultation; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha

2012

Trials

2 trial(s) available for isoxazoles and Synovitis

ArticleYear
Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine
    Arthritis and rheumatism, 2000, Volume: 43, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Humans; Immunohistochemistry; Isoxazoles; Leflunomide; Metalloendopeptidases; Prospective Studies; Synovial Membrane; Synovitis; Therapeutic Equivalency

2000
Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:2

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prospective Studies; Synovitis; Treatment Outcome

2002

Other Studies

3 other study(ies) available for isoxazoles and Synovitis

ArticleYear
Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:1

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Calcification, Physiologic; Cell Differentiation; Disease Models, Animal; Isoxazoles; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Osteoblasts; Osteoclasts; Propionates; Receptors, Lysophosphatidic Acid; Synovitis

2014
Factors influencing ultrasonographic remission in patients with rheumatoid arthritis.
    Rheumatology international, 2015, Volume: 35, Issue:3

    Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Delayed Diagnosis; Etanercept; Female; Hand Joints; Humans; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Tenosynovitis; Time Factors; Ultrasonography, Doppler

2015
Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Nov-15, Volume: 179, Issue:10

    Topics: Aniline Compounds; Apoptosis; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Chronic Disease; Crotonates; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Hydroxybutyrates; Immunosuppressive Agents; Inflammation Mediators; Isoxazoles; Leflunomide; Mast Cells; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Synovial Membrane; Synovitis; Toluidines; Uridine

2007